3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes

ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.

Zacks Investment Research • Feb 23, 2026

Intuitive Surgical: This Robotic-Surgery Leader Could Keep Compounding for Another Decade

Intuitive Surgical can overcome recent headwinds thanks to its robust competitive edge. The robotics-assisted surgery specialist still has significant growth avenues ahead of it.

The Motley Fool • Feb 22, 2026

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Novo Nordisk's GLP-1 pill has reignited the competition in the GLP-1 space. But you can sidestep that drama by buying this surgical robotics pioneer.

The Motley Fool • Feb 20, 2026

Could Intuitive Surgical Be the One Medtech Stock to Hold Through Any Market Crash?

Intuitive Surgical dominates the robotic surgery market. The company sells surgical platforms, accessories, and service contracts.

The Motley Fool • Feb 19, 2026

Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks Investment Research • Feb 19, 2026

ISRG's International Growth Outpaces US With 35% Procedure Volume

Intuitive Surgical sees international procedures jump 23% in 2025, now 35% of total, outpacing U.S. growth and reshaping its long-term expansion strategy.

Zacks Investment Research • Feb 19, 2026

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research • Feb 17, 2026

My 1 Top AI Healthcare Stock to Buy and Hold Forever

Intuitive Surgical is the 800-pound gorilla in the robotic surgery realm. It has more than 11,000 systems installed worldwide.

The Motley Fool • Feb 16, 2026

Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?

Intuitive Surgical balances 22% EPS growth with heavier 2026 R&D and expansion spending, betting near-term margin pressure will fuel long-term demand.

Zacks Investment Research • Feb 13, 2026

Should You Buy ISRG Stock Despite a 13% Fall in Three Months?

Shares of Intuitive Surgical ISRG have declined 13.5% over the past three months, despite continued strong procedure growth and robust adoption of the da Vinci 5 system in fourth-quarter 2025. Over the same period, the company's shares lagged the industry's 8% decline and significantly underperformed the S&P 500 Index, which rose 2.8%.

Zacks Investment Research • Feb 11, 2026